1SCHWARTZ G G,OLSSON A G,EZEKOWITZ M D,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial[J].JAMA,2001,285 (13):1711-1718.
2CHALASANI N,ALJADHEY H,KESTERSON J,et al.Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity[J].Gastroenterology,2004,126 (5):1287-1292.
3CANNON C P,BRAUNWALD E,MCLABE C H,et al.Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators.intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350 (15):1495-1504.
4Wang E, Casciano CN, Clement RP, et al. HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein.Pharm Res, 2001, 18:800 - 806.
5Laufs U, Gertz K, Huang P, et al. Atorvastatin upregulates type Ⅲ nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke,2000, 31:2442 - 2449.
6Gibson Wood W, Eckert GP, Igbavboa U, et al. Amyloid β-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochim Biophys Acta, 2003, 1610:281 - 290.
8Frears ER, Stephens DJ, Waiters CE, et al. The role of cholesterol in the biosynthesis of β-amyloid. Neuroreport, 1999, 10:1699 - 1705.
9Naidu A, Xu Q, Catalano R, et al. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins.Brain Res, 2002, 958:100 - 111.
10Poirier J. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann N Y Acad Sci, 2000, 924:81 - 90.
